NCT01875380View on ClinicalTrials.gov

Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Colorectal NeoplasmsMetastatic Disease
Interventions
DRUG

Regorafenib

Trial Locations (1)

28046

Spanish Cooperative Group for Digestive Tumour Therapy (TTD), Madrid

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

OTHER

NCT01875380 - Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter